My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.

    Fiancette R, Rouaud P, Vincent-Fabert C, Laffleur B, Magnone V, Cogné M, Denizot Y.

    J Immunol. 2011 Dec 1;187(11):5772-82. Epub 2011 Oct 28.

    PMID:
    22039300
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Wnt5a is secreted by follicular dendritic cells to protect germinal center B cells via Wnt/Ca2+/NFAT/NF-κB-B cell lymphoma 6 signaling.

    Kim J, Kim DW, Chang W, Choe J, Kim J, Park CS, Song K, Lee I.

    J Immunol. 2012 Jan 1;188(1):182-9. Epub 2011 Nov 28.

    PMID:
    22124122
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis.

    McPhee CG, Sproule TJ, Shin DM, Bubier JA, Schott WH, Steinbuck MP, Avenesyan L, Morse HC 3rd, Roopenian DC.

    J Immunol. 2011 Nov 1;187(9):4695-704. Epub 2011 Sep 30.

    PMID:
    21964024
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.

    Lask A, Goichberg P, Cohen A, Goren-Arbel R, Milstein O, Aviner S, Feine I, Ophir E, Reich-Zeliger S, Hagin D, Klein T, Nagler A, Berrebi A, Reisner Y.

    J Immunol. 2011 Aug 15;187(4):2006-14. Epub 2011 Jul 13.

    PMID:
    21753148
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3.

    Arita K, Endo S, Kaifu T, Kitaguchi K, Nakamura A, Ohmori H, Kohu K, Satake M, Takai T.

    J Immunol. 2011 Jun 15;186(12):7050-9. Epub 2011 May 9.

    PMID:
    21555536
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.

    Bedognetti D, Zoppoli G, Massucco C, Zanardi E, Zupo S, Bruzzone A, Sertoli MR, Balleari E, Racchi O, Messina M, Caltabiano G, Icardi G, Durando P, Marincola FM, Boccardo F, Ferrarini M, Ansaldi F, De Maria A.

    J Immunol. 2011 May 15;186(10):6044-55. Epub 2011 Apr 15.

    PMID:
    21498665
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    7.

    EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

    van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME.

    J Immunol. 2011 Feb 1;186(3):1694-702. Epub 2010 Dec 29.

    PMID:
    21191071
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    8.

    CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.

    O'Reilly MK, Tian H, Paulson JC.

    J Immunol. 2011 Feb 1;186(3):1554-63. Epub 2010 Dec 22.

    PMID:
    21178016
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    9.

    Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.

    Fernández A, Mesa C, Marigo I, Dolcetti L, Clavell M, Oliver L, Fernández LE, Bronte V.

    J Immunol. 2011 Jan 1;186(1):264-74. Epub 2010 Dec 6.

    PMID:
    21135171
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    10.

    Methyl gallate exhibits potent antitumor activities by inhibiting tumor infiltration of CD4+CD25+ regulatory T cells.

    Lee H, Lee H, Kwon Y, Lee JH, Kim J, Shin MK, Kim SH, Bae H.

    J Immunol. 2010 Dec 1;185(11):6698-705. Epub 2010 Nov 3.

    PMID:
    21048105
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    11.

    CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination.

    Vicetti Miguel RD, Cherpes TL, Watson LJ, McKenna KC.

    J Immunol. 2010 Dec 1;185(11):6706-18. Epub 2010 Nov 1.

    PMID:
    21041723
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    12.

    Invariant NKT cells are required for antitumor responses induced by host-versus-graft responses.

    Saito TI, Li HW, Sykes M.

    J Immunol. 2010 Aug 15;185(4):2099-105. Epub 2010 Jul 14.

    PMID:
    20631307
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    13.

    CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors.

    Haynes NM, Hawkins ED, Li M, McLaughlin NM, Hämmerling GJ, Schwendener R, Winoto A, Wensky A, Yagita H, Takeda K, Kershaw MH, Darcy PK, Smyth MJ.

    J Immunol. 2010 Jul 1;185(1):532-41. Epub 2010 May 26.

    PMID:
    20505139
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    14.

    Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.

    Merlo A, Turrini R, Bobisse S, Zamarchi R, Alaggio R, Dolcetti R, Mautner J, Zanovello P, Amadori A, Rosato A.

    J Immunol. 2010 May 15;184(10):5895-902. Epub 2010 Apr 12.

    PMID:
    20385879
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk